Canaccord Genuity lifts Saluda Medical price target 1% to A$2.02
Canaccord Genuity raised its Saluda Medical price target by 1% to A$2.02 per share.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.